Less Ads, More Data, More Tools Register for FREE

Monday broker round-up UPDATE

Mon, 16th Jun 2014 09:51
Allocate Software: N+1 Singer upgrades to buy with a target price of 133p.Croda International: Numis cuts target price from 2575p to 2554p and maintains its hold recommendation.Diamondcorp: Northland Capital shifts target price from 9.9p to 11p and keeps a buy recommendation.Fenner: Credit Suisse reduces target price from 490p to 405p and stays with its outperform rating.GlaxoSmithKline: Societe Generale ups target price from 2075p to 2100p and retains a buy recommendation.Glencore Xstrata: Investec moves target price from 302p to 319p upgrading from reduce to hold.Halma: Credit Suisse ups target price from 620p to 665p and reiterates an outperform rating.IG Group: Canaccord Genuity cuts target price from 711p to 659p, while staying with its buy recommendation.Laird: Credit Suisse raises target price from 215p to 270p, while leaving its underperform rating unchanged.Lamprell: Investec shifts target price from 150p to 155p and reiterates a hold recommendation.Morgan Advanced Materials: Credit Suisse ups target price from 270p to 310p and maintains an underperform rating.Oxford Instruments: N+1 Singer ups target price to 1445p and maintains its hold recommendation.Petra Diamonds: Numis moves target price from 200p to 220p keeping its buy recommendation.Reckitt Benckiser: Exane raises target price from 4500p to 4900p, while staying with its underperform rating.Rio Tinto: Investec reduces target price from 3624p to 3128p downgrading from buy to hold. Exane reduces target price from 4070p to 3800p and stays with its outperform rating.Rolls-Royce Group: Societe Generale reduces target price from 1070p to 950p downgrading from hold to sell.Rotork: Credit Suisse increases target price from 2450p to 2600p and stays with its neutral rating.Senior: Credit Suisse moves target price from 315p to 335p and keeps an outperform rating.Science in Sport: Sanlam Securities initiates with a target price of 83p and a buy recommendation.Zambeef: Panmure Gordon reinstates with a target price of 30p and a buy recommendation. Senior Halma Rio Tinto Oxford Instruments IG Zambeef Prod. Glaxosmithkline Rotork Glencore Croda International Morgan Advanced Materials Atlantic Lithium

Shares in this article

Related News

Chile's May copper output falls sharply across top miners
1 hour ago

Chile's May copper output falls sharply across top miners

SANTIAGO, July ​10 (Reuters) - ⁠Chile's ​copper output from major ​producers ‌fell ⁠sharply in May, ⁠according ​to data published by state copper ​com...

Mining Anglo American + 1 more share
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
6 hours ago

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial

* GSK partner Hansoh reports first late-stage data ​for experimental ⁠lung cancer drug

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
8 hours ago

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...